Showing results (21-30 of 26) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Plos One|January 28, 2014
Randomised pharmacokinetic trial of rifabutin with lopinavir/ritonavir-antiretroviral therapy in patients with HIV-associated tuberculosis in VietnamNguyen Thi Ngoc Lan, Nguyen Thi Nguyet Thu, Aurélie Barrail-Tran, et al.Lancet (London, England)|March 22, 2015
Efficiency and safety of the combination of moxifloxacin, pretomanid (PA-824), and pyrazinamide during the first 8 weeks of antituberculosis treatment: a phase 2b, open-label, partly randomised trial in patients with drug-susceptible or drug-resistant pulmonary tuberculosisRodney Dawson, Andreas H Diacon, Daniel Everitt, et al.Journal of Medical Ethics|August 21, 2013
Consensus standards for introductory e-learning courses in human participants research ethicsJohn R Williams, Dominique Sprumont, Marie Hirtle, et al.The New England Journal of Medicine|June 5, 2009
The diarylquinoline TMC207 for multidrug-resistant tuberculosisAndreas H Diacon, Alexander Pym, Martin Grobusch, et al.The Lancet. Global Health|January 27, 2019
Effect of Xpert MTB/RIF on clinical outcomes in routine care settings: individual patient data meta-analysisGian Luca Di Tanna, Ali Raza Khaki, Grant Theron, et al.The New England Journal of Medicine|October 4, 2018
Prediction of Susceptibility to First-Line Tuberculosis Drugs by DNA Sequencing, Caroline Allix-Béguec, Irena Arandjelovic, et al.Pageof 3